Bristol-Myers Squibb Company Price Today
Bristol-Myers Squibb Company
BMY
Healthcare
$103.57B
💰
Market Cap
13.2
💸
Price to Earnings
$3.9
🎉
EPS
+77
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
6 |
Strong Buy |
4 |
Hold |
20 |
Sell |
1 |
Strong Sell |
0 |
BMY Price Forecast Target
51.1 👉 69.1 +35%
BMY EPS Forecast
3.9 👉 6.5 +69%
Financials
Profit Margin
18 %
Revenue Growth
0.6 %
Dividend
$ 2.4
Held Percent
0.1% - Insiders
79.0% - Institutions
20.9% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $10.1B
-
💰 Blackrock Inc. $8.6B
-
💰 JP Morgan Chase & Company $4.6B
-
💰 State Street Corporation $4.6B
-
💰 Capital International Investors $3.1B
Stock Ideas
Bruce Berkowitz Portfolio
Bruce Berkowitz, the esteemed founder of Fairholme, has established himself as a prominent figure in the investment world with his exceptional portfolio strategy. Since its inception in 1999, Fairholme has grown into a formidable $19 billion mutual …
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
David Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While litt…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …📮FAQ
Some Frequently Asked Questions.
The Bristol-Myers Squibb Company industry is Drug Manufacturers - General
The Bristol-Myers Squibb Company sector is Healthcare
The Bristol-Myers Squibb Company forecasted predicted Price to Earnings PE ratio is 7.8
The Bristol-Myers Squibb Company Price to Earnings PE ratio is 13.2
The Market Capitalization of Bristol-Myers Squibb Company is $103.57B
There are total of 2018068136 float shares with 79.0% held by Institutions and 0.1% held by insiders
The MBristol-Myers Squibb Company forecasted Earnings per Share EPS is $6.5
The Bristol-Myers Squibb Company Earnings per Share EPS is 3.9
The Bristol-Myers Squibb Company company has $0 gross profits with 18 profit margins
The Bristol-Myers Squibb Company Earnings Growth is -0.089% with -0.129% quarterly earnings growth
The Bristol-Myers Squibb Company Revenue is $45006000128 with 0.006 revenue growth
The price target for Bristol-Myers Squibb Company stock is $69.1 for the high target and $37.8 for the low target
The consensus analyst recommendations for Bristol-Myers Squibb Company is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bristol-Myers Squibb Company is Hold, with the following breakdown:
- Buy: 6
- Strong Buy: 4
- Hold: 20
- Sell: 1
- Strong Sell: 0
The Beta of Bristol-Myers Squibb Company is 0.4
The dividend of Bristol-Myers Squibb Company is $2.4
The dividend yield of Bristol-Myers Squibb Company is 0.047%
The biggest institutional and mutual fund holders of Bristol-Myers Squibb Company stock are
- Vanguard Group Inc
- Blackrock Inc.
- JP Morgan Chase & Company
- State Street Corporation
The Bristol-Myers Squibb Company ESG Score is 77, with the following breakdown:
- E: 1.31
- S: 14.37
- G: 7.07